MEREDITH MCCOY: Open Payments
NPI 1174079198 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$505 in 23 payments from 13 companies in 2025. Trend: 2023 $944 · 2024 $555 · 2025 $505
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 1 | $102 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Dexcom, Inc. | 5 | $88 |
| Abbott Laboratories | 2 | $45 |
| Novo Nordisk Inc | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: Exparel, Dexcom G6 Transmitter, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, AREXVY, Wegovy, XIFAXAN, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
